Methyl 4,4-dimethoxybutanoate → HCID 178495093, Verbindung
Reaktionsgleichung
Cl.Cl.Cl.[O:4]1[C:8]2=[C:9]([N:13]3[CH2:18][CH2:17][N:16]([CH2:19][CH2:20][C@H:21]4[CH2:26][CH2:25][C@H:24]([NH2:27])[CH2:23][CH2:22]4)[CH2:15][CH2:14]3)[N:10]=[CH:11][CH:12]=[C:7]2[CH2:6][CH2:5]1.[CH3:28][O:29][CH:30]([O:37][CH3:38])[CH2:31][CH2:32][C:33](OC)=[O:34]>>[O:4]1[C:8]2=[C:9]([N:13]3[CH2:18][CH2:17][N:16]([CH2:19][CH2:20][C@H:21]4[CH2:26][CH2:25][C@H:24]([NH:27][C:33](=[O:34])[CH2:32][CH2:31][CH:30]([O:37][CH3:38])[O:29][CH3:28])[CH2:23][CH2:22]4)[CH2:15][CH2:14]3)[N:10]=[CH:11][CH:12]=[C:7]2[CH2:6][CH2:5]1Komponenten
3
Versuchsvorschrift
The title compound, white solid (110 mg, 96%), MS (ISP) m/z=461.4 [(M+H)+], mp 204.5° C., was prepared in accordance with the general method of example 5 from trans-4-{2-[4-(2,3-dihydro-furo[2,3-c]pyridin-7-yl)-piperazin-1-yl]-ethyl}-cyclohexylamine trihydrochloride (intermediate B) (110 mg, 0.25 mmol) and methyl 4,4-dimethoxy-butanoate.
Quellen und Nachweise
- ORD-Eintrag
- ord-0b6ff4c99d5a49dfbe315039a1d40200
- Quelldatensatz
- uspto-grants-2013_06
- Patentnummer
- US08470828B2
Notizen zur Reaktion
Wird geladen…